WAT
41
3
MO
42
-8
ADT
20
-2
DAL
46
-12
SWKS
65
5
UAL
35
-6
URBN
56
-2
SEE
38
-4
RSG
70
2
LH
52
4
ADI
61
-2
AME
59
-9
MS
57
-2
EXC
37
2
HP
48
18
ALL
41
-2
CMA
33
-3
RCL
61
-8
WYNN
25
-3
EQT
34
-5
WAT
41
3
MO
42
-8
ADT
20
-2
DAL
46
-12
SWKS
65
5
UAL
35
-6
URBN
56
-2
SEE
38
-4
RSG
70
2
LH
52
4
ADI
61
-2
AME
59
-9
MS
57
-2
EXC
37
2
HP
48
18
ALL
41
-2
CMA
33
-3
RCL
61
-8
WYNN
25
-3
EQT
34
-5
Financhill
Back

Brainstorm Cell Therapeutics Vs. Bombardier Industry Stock Comparison

Sell
43

BCLI
Brainstorm Cell Therapeutics

Last Price:
0.48
Seasonality Move:
24.67%
Buy
59

BDRBF
Bombardier

Last Price:
61.37
Seasonality Move:
1.59%
Sell
43
Brainstorm Cell Therapeutics (BCLI) is a Sell

Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?

  • The current Brainstorm Cell Therapeutics [BCLI] share price is $0.47. The Score for BCLI is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BCLI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Bombardier (BDRBF) is a Buy

Is Bombardier a Buy, Sell or Hold?

  • The current Bombardier [BDRBF] share price is $61.37. The Score for BDRBF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • BDRBF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BCLI Stock Price Chart

What is Brainstorm Cell Therapeutics's stock price today?

BDRBF Stock Price Chart

What is Bombardier's stock price today?

  • The Bombardier share price today is $61.37
    The current trend is moderately bearish and BDRBF is experiencing slight selling pressure.

BCLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 48.81 Sell
Chaikin Money Flow: -746129 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.44 - 0.54) Sell
Bollinger Bands (100): (0.35 - 0.57) Buy

BDRBF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.68 Buy
Relative Strength Index (14 RSI): 51.64 Buy
Chaikin Money Flow: -9235 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.29 - 66.71) Sell
Bollinger Bands (100): (36.24 - 56.54) Buy

BCLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.44 Buy
20-day SMA: 0.49 Sell
50-day SMA: 0.5 Sell
200-day SMA: 0.43 Buy
8-day EMA: 0.45 Buy
20-day EMA: 0.47 Sell
50-day EMA: 0.48 Sell
200-day EMA: 0.69 Sell

BDRBF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.24 Sell
20-day SMA: 63.9 Sell
50-day SMA: 53.9 Buy
200-day SMA: 41.42 Buy
8-day EMA: 63.71 Sell
20-day EMA: 62.33 Sell
50-day EMA: 56.01 Buy
200-day EMA: 45.28 Buy

Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.18 per share.

Bombardier Earnings Growth & BDRBF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.39 per share, an increase this year of $0.42 per share, and an increase next year of $2.20 per share.

Brainstorm Cell Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bombardier Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):